πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,152 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7619057

MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7612044

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7605125

DNA-binding polyamide drug conjugates

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7598225

Generation of immune response to prostate-specific antigen (PSA)

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7598077

Compositions and methods for enhancing differential expression

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585841

Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7585667

Negative strand RNA virus replicon

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Sep 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7576050

GLP-1 exendin-4 peptide analogs and uses thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572771

Multi-domain amphipathic helical peptides and methods of their use

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572887

Gene expressed in prostate cancer, methods and use thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7569673

Humanized anti-tag 72 cc49 for diagnosis and therapy of human tumors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7566451

Human immunodeficiency virus-neutralizing human antibodies with improved breadth and poten

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7560118

Attenuated dengue virus comprising mutations in the NS3 gene

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jul 14 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 09 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7547762

T24 antigen for immunodiagnosis of Taenia solium cysticercosis

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7547773

Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7544789

DNA encoding Toxoplasma gondii rDGP5p protein

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541034

Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541139

Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7541043

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jun 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 28 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7537765

Inhibition of HIV-1 replication by disruption of the processing of the viral capsid-spacer

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7534565

DLC-1 gene deleted in cancers

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 19 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7531352

Inducible plasmid vector encoding TGF-Ξ² and use thereof

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 12 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 07 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7528274

Acylthiols and component thiol compositions as anti-HIV and anti-retroviral agents

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue May 05 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7524508

Subgenomic replicons of the flavivirus dengue

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Apr 28 2009 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 23 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted